May 09, 2023 Gene editing: overhyped or unstoppable tide? A new report from Evaluate Vantage looks at recent developments in gene editing and delivery.
November 14, 2022 Ionis gets into gene editing The company insists its $80m tie-up with Metagenomi will not lead to a loss of focus.
April 05, 2022 Venture funding stays strong despite the gloom But how long can the money keep rolling in?
